Long Road Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.79M | Hold |
7,711
| – | – | 1.49% | 22 |
|
|
2025
Q4 | $4.47M | Buy |
7,711
+185
| +2% | +$105K | 1.69% | 17 |
|
|
2025
Q3 | $3.65M | Hold |
7,526
| – | – | 1.29% | 23 |
|
|
2025
Q2 | $3.05M | Sell |
7,526
-95
| -1% | -$39.7K | 1.14% | 27 |
|
|
2025
Q1 | $3.79M | Buy |
7,621
+300
| +4% | +$162K | 1.47% | 23 |
|
|
2024
Q4 | $3.81M | Sell |
7,321
-100
| -1% | -$55K | 1.55% | 23 |
|
|
2024
Q3 | $4.59M | Hold |
7,421
| – | – | 1.83% | 20 |
|
|
2024
Q2 | $4.1M | Hold |
7,421
| – | – | 1.79% | 20 |
|
|
2024
Q1 | $4.31M | Sell |
7,421
-950
| -11% | -$533K | 1.81% | 20 |
|
|
2023
Q4 | $4.51M | Buy |
8,371
+830
| +11% | +$402K | 1.87% | 19 |
|
|
2023
Q3 | $3.82M | Hold |
7,541
| – | – | 1.85% | 21 |
|
|
2023
Q2 | $3.94M | Sell |
7,541
-150
| -2% | -$80.9K | 1.83% | 22 |
|
|
2023
Q1 | $4.43M | Buy |
7,691
+50
| +0.7% | +$28.2K | 2.13% | 19 |
|
|
2022
Q4 | $4.21M | Sell |
7,641
-200
| -3% | -$106K | 2.09% | 21 |
|
|
2022
Q3 | $3.98M | Hold |
7,841
| – | – | 2.18% | 16 |
|
|
2022
Q2 | $4.26M | Sell |
7,841
-50
| -0.6% | -$27.5K | 2.18% | 16 |
|
|
2022
Q1 | $4.66M | Sell |
7,891
-852
| -10% | -$489K | 2.09% | 18 |
|
|
2021
Q4 | $5.83M | Sell |
8,743
-962
| -10% | -$601K | 2.32% | 16 |
|
|
2021
Q3 | $5.54M | Hold |
9,705
| – | – | 2.44% | 15 |
|
|
2021
Q2 | $4.9M | Sell |
9,705
-1,000
| -9% | -$472K | 2.14% | 16 |
|
|
2021
Q1 | $4.89M | Hold |
10,705
| – | – | 2.2% | 15 |
|
|
2020
Q4 | $4.99M | Sell |
10,705
-50
| -0.5% | -$23.4K | 2.42% | 12 |
|
|
2020
Q3 | $4.75M | Buy |
10,755
+50
| +0.5% | +$20.7K | 2.68% | 11 |
|
|
2020
Q2 | $3.88M | Hold |
10,705
| – | – | 2.29% | 14 |
|
|
2020
Q1 | $3.04M | Buy |
10,705
+300
| +3% | +$94.6K | 2.17% | 16 |
|
|
2019
Q4 | $3.38M | Sell |
10,405
-50
| -0.5% | -$15.2K | 2% | 16 |
|
|
2019
Q3 | $3.04M | Hold |
10,455
| – | – | 1.77% | 18 |
|
|
2019
Q2 | $3.07M | Sell |
10,455
-780
| -7% | -$215K | 1.81% | 16 |
|
|
2019
Q1 | $3.08M | Hold |
11,235
| – | – | 1.88% | 17 |
|
|
2018
Q4 | $2.51M | Sell |
11,235
-1,925
| -15% | -$452K | 1.92% | 19 |
|
|
2018
Q3 | $3.21M | Hold |
13,160
| – | – | 2.13% | 13 |
|
|
2018
Q2 | $2.73M | Sell |
13,160
-700
| -5% | -$149K | 1.93% | 19 |
|
|
2018
Q1 | $2.86M | Hold |
13,860
| – | – | 2% | 15 |
|
|
2017
Q4 | $2.63M | Sell |
13,860
-30
| -0.2% | -$5.75K | 1.82% | 20 |
|
|
2017
Q3 | $2.63M | Hold |
13,890
| – | – | 1.87% | 18 |
|
|
2017
Q2 | $2.42M | Sell |
13,890
-70
| -0.5% | -$11.8K | 1.78% | 18 |
|
|
2017
Q1 | $2.14M | Hold |
13,960
| – | – | 1.58% | 24 |
|
|
2016
Q4 | $1.97M | Hold |
13,960
| – | – | 1.51% | 24 |
|
|
2016
Q3 | $2.22M | Sell |
13,960
-50
| -0.4% | -$7.71K | 1.71% | 19 |
|
|
2016
Q2 | $2.07M | Hold |
14,010
| – | – | 1.62% | 20 |
|
|
2016
Q1 | $1.98M | Hold |
14,010
| – | – | 1.56% | 20 |
|
|
2015
Q4 | $1.99M | Hold |
14,010
| – | – | 1.63% | 21 |
|
|
2015
Q3 | $1.71M | Buy |
14,010
+250
| +2% | +$32.6K | 1.46% | 22 |
|
|
2015
Q2 | $1.78M | Hold |
13,760
| – | – | 1.45% | 26 |
|
|
2015
Q1 | $1.85M | Hold |
13,760
| – | – | 1.57% | 24 |
|
|
2014
Q4 | $1.72M | Buy |
+13,760
| New | +$1.67M | 1.55% | 28 |
|
Other funds holding TMO
VCM
Long Road Investment Counsel's TMO Position: Q1 2026 in Review
Long Road Investment Counsel held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 7,711 shares worth $3.79M. The position accounts for 1.49% of the portfolio, ranked #22.
Long Road Investment Counsel first reported a position in TMO in Q4 2014 and has held it in 46 quarters since. The position peaked at $5.83M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Long Road Investment Counsel held 7,711 shares of Thermo Fisher Scientific worth $3.79M as of Q1 2026.
- Long Road Investment Counsel left its Thermo Fisher Scientific share count unchanged in Q1 2026.
- Thermo Fisher Scientific made up 1.49% of Long Road Investment Counsel's portfolio in Q1 2026, its #22 holding.
- Long Road Investment Counsel first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 46 quarters since.
- Long Road Investment Counsel's Thermo Fisher Scientific position peaked at $5.83M in Q4 2021.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Long Road Investment Counsel's 13F filing for Q1 2026, filed 8 May 2026.